The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.
Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–239 of 239
Isothermally Sensitive Detection of Serum Circulating miRNAs for Lung Cancer Diagnosis
Li, Y., Liang, L., & Zhang, C. (2013) · Analytical Chemistry · doi:10.1021/ac403462f · Cited by 94
Chen, Q., Ge, X., Zhang, Y., Xia, H., Yuan, D., Tang, Q., Chen, L., PANG, X., Leng, W., & Bi, F. (2014) · Oncology Reports · doi:10.3892/or.2014.3004 · Cited by 94
Cookson, V. J., Bentley, M. A., Hogan, B. V., Horgan, K. J., Hayward, B. E., Hazelwood, L. D., & Hughes, T. A. (2012) · Cellular Oncology · doi:10.1007/s13402-012-0089-1 · Cited by 93
Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.
Komatsu, S., Ichikawa, D., Tsujiura, M., Konishi, H., Takeshita, H., Nagata, H., Kawaguchi, T., Hirajima, S., Arita, T., Shiozaki, A., et al. (2013) · PubMed · Cited by 90
Circulating miR‐34a levels are reduced in colorectal cancer
Nugent, M., Miller, N., & Kerin, M. J. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23174 · Cited by 88
Zearo, S., Kim, E., Zhu, Y., Zhao, J., Sidhu, S. B., Robinson, B. G., & Soon, P. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-200 · Cited by 87
Validation of Circulating miRNA Biomarkers for Predicting Lymph Node Metastasis in Gastric Cancer
Kim, S. Y., Jeon, T. Y., Choi, C. I., Kim, D. H., Kim, D. H., Kim, G. H., Ryu, D. Y., Lee, B. E., & Kim, H. H. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.04.004 · Cited by 86
Han, H., Yun, J., Lim, S.-N., Han, J., Lee, K. H., Kim, S. T., Kang, M., Son, S., Lee, Y., Choi, S., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28054 · Cited by 84
Prognostic implications of serum microRNA-21 in colorectal cancer
Menéndez, P. R., Padilla, D., Villarejo‐Campos, P., Palomino, T., Nieto, P., Menéndez, J. M., & Rodríguez‐Montes, J. A. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23415 · Cited by 84
Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion
Yu, J., Wang, Y., Dong, R., Huang, X., Ding, S., & Qiu, H. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1147-9 · Cited by 84
Exosomal tumor-suppressive microRNAs as novel cancer therapy
Kosaka, N., Takeshita, F., Yoshioka, Y., Hagiwara, K., Katsuda, T., Ono, M., & Ochiya, T. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.011 · Cited by 82
MiRNA‐199a‐3p: A potential circulating diagnostic biomarker for early gastric cancer
Li, C., Li, J. F., Cai, Q., Qiu, Q. Q., Yan, M., Liu, B., & Zhu, Z. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23358 · Cited by 81
Higher expression of circulating miR-182 as a novel biomarker for breast cancer
Wang, P., Hai-tao, G., Li, B., LV, C.-L., WANG, H.-T., ZHOU, H.-H., Li, X., Xie, S., & Jiang, B. (2013) · Oncology Letters · doi:10.3892/ol.2013.1593 · Cited by 81
Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy
Zhang, J., Zhang, K., Bi, M., Jiao, X., Zhang, D., & Dong, Q. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000049 · Cited by 81
Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer
Zeng, R., Zhang, W., Yan, X.-Q., Ye, Z., Chen, E., Huang, D.-P., Zhang, X., & Huang, G. (2013) · Medical Oncology · doi:10.1007/s12032-013-0477-z · Cited by 80
Determination of plasma microRNA for early detection of gastric cancer
Görür, A., Balcı, Ş., Ünal, N., Ayaz, L., Akbayir, S., Yaroğlu, H. Y., Dirlik, M., Serin, M. S., & Tamer, L. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2267-7 · Cited by 79
Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas
Papachristou, D. J., Korpetinou, A., Giannopoulou, E., Antonacopoulou, A. G., Papadaki, H. H., Grivas, P. D., Scopa, C. D., & Kalofonos, H. P. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1119-5 · Cited by 79
Diagnostic and Prognostic Value of Circulating miR-221 for Extranodal Natural Killer/T-Cell Lymphoma
Guo, H., Huang, G., Guo, C., Pu, X., & Lin, T.-Y. (2010) · Disease Markers · doi:10.1155/2010/474692 · Cited by 78
MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients
Zheng, Y., Cui, L., Sun, W., Zhou, H., Yuan, X., Huo, M., Chen, J., Lou, Y., & Guo, J. (2012) · Cancer Biomarkers · doi:10.3233/cbm-2011-0231 · Cited by 77
New roles for microRNAs in cross-species communication
Liang, H., Zen, K., Zhang, J., Zhang, C., & Chen, X. (2013) · RNA Biology · doi:10.4161/rna.23663 · Cited by 76
Chen, W., Wang, H., Chen, H., Liu, S., Lu, H., Kong, D., Huang, X., Kong, Q., & Lu, Z. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12263 · Cited by 76
Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients
Kaduthanam, S., Gade, S., Meister, M. A., Brase, J. C., Johannes, M., Dienemann, H., Warth, A., Schnabel, P. A., Herth, F. J. F., Sültmann, H., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.01.013 · Cited by 74
Differential profiling of human red blood cells during storage for 52 selected microRNAs
Kannan, M., & Atreya, C. (2010) · Transfusion · doi:10.1111/j.1537-2995.2010.02585.x · Cited by 70
Slesak, B., Harłoziñska-Szmyrka, A., Knast, W., Sedlaczek, P., van Dalen, A., & EINARSSON, R. (2000) · Cancer · Cited by 68
Aberrant expression of miR‐196a in gastric cancers and correlation with recurrence
Tsai, K., Liao, Y., Wu, C., Hu, L., Li, S., Chan, W., Ho, M., Lai, C., Kao, H., Fang, W., et al. (2012) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.21924 · Cited by 68
Jiang, Y., Chen, J., Wu, J., Hu, Z., Qin, Z., Liu, X., Guan, X., Wang, Y., Han, J., Jiang, T., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28237 · Cited by 63
Plasma mi R ‐21 is a novel diagnostic biomarker for biliary tract cancer
Kishimoto, T., Eguchi, H., Nagano, H., Kobayashi, S., Akita, H., Hama, N., Wada, H., Kawamoto, K., Tomokuni, A., Tomimaru, Y., et al. (2013) · Cancer Science · doi:10.1111/cas.12300 · Cited by 62
Kannan, M., Mohan, K. V. K., Kulkarni, S., & Atreya, C. D. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02140.x · Cited by 60
MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients
Zhou, H. F., Xiao, B., Zhou, F., Deng, H., Zhang, X., Lou, Y., Gong, Z., Du, C., & Guo, J. (2012) · Biomarkers · doi:10.3109/1354750x.2011.614961 · Cited by 59
Fu, Y., Wei, X., Tang, C., Li, J., Liu, R., Shen, A., & Wu, Z. (2013) · Oncology Letters · doi:10.3892/ol.2013.1638 · Cited by 57
Vychytilova‐Faltejskova, P., Bočánek, O., Šachlová, M., Svoboda, M., Kišš, I., Vyzula, R., & Slabý, O. (2013) · Cancer Biomarkers · doi:10.3233/cbm-130308 · Cited by 55
Disruption of microRNA nuclear transport in human cancer
Melo, S. A., & Esteller, M. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.02.012 · Cited by 51
Muraoka, T., Soh, J., Toyooka, S., Aoe, K., Fujimoto, N., Hashida, S., Maki, Y., Tanaka, N., Shien, K., Furukawa, M., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.09.017 · Cited by 51
The Identification of miR-375 as a Potential Biomarker in Distal Gastric Adenocarcinoma
Zhang, W., Gui, J.-H., Wang, C., Chang, Q., Xu, S.-P., Cai, C.-H., Li, Y., Tian, Y., Li, Y., & Wu, B. (2012) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504012x13522227232156 · Cited by 50
Yang, I., Tsai, H., Huang, C., Huang, M., Hou, M., Juo, S. H., & Wang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066842 · Cited by 48
Cell-Free Plasma MicroRNA in Pancreatic Ductal Adenocarcinoma and Disease Controls
Carlsen, A. L., Jøergensen, M. T., Knudsen, S., de Muckadell, O. B. S., & Heegaard, N. H. H. (2013) · Pancreas · doi:10.1097/mpa.0b013e318296bb34 · Cited by 30
Bianchi, F., Nicassio, F., Veronesi, G., & Fiore, P. P. D. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2012.246 · Cited by 18
Ho, S., Chan, H., Wong, R. N., & Li, H. (2014) · Analytica Chimica Acta · doi:10.1016/j.aca.2014.03.020 · Cited by 15
MicroRNAs as Therapeutic Targets for Cancer
Cheng, G., Danquah, M. K., & Mahato, R. I. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0131-6_14 · Cited by 9
Self-citation
Cited by
Immunotherapy and Prevention of Pancreatic Cancer
Morrison, A. H., Byrne, K. T., & Vonderheide, R. H. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.04.001 · Cited by 464
Circulating MicroRNAs in Cancer: Potential and Challenge
Cui, M., Wang, H., Yao, X., Zhang, D., Xie, Y., Cui, R., & Zhang, X. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00626 · Cited by 418
Cell-to-cell communication: microRNAs as hormones.
Bayraktar, R., Van Roosbroeck, K., & Calin, G. A. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12144 · Cited by 361
Metadata
- Authors
- Cheng, G.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 81
- Pages
- 75-93
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2069295843
- Cited by
- 334
- References
- 239
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.